Oncology Research2026，Vol.34Issue(9)：P.496-513,18.DOI:10.32604/or.2026.083962
miR-152-3p Overcomes Temozolomide Resistance in Glioblastoma by Targeting TGF-αand Enhancing Apoptosis
Chun-Nun Chao 1Chiung-Yao Fang 2Chia-Hsin Hou 3Jen-Tsung Yang 4Yu-Ping Wu 5Jui-Chieh Chen6
作者信息
- 1. Department of Pediatrics,Ditmanson Medical Foundation Chiayi Christian Hospital,Chiayi,Taiwan,China Institute of Molecular Biology,National Chung Cheng University,Chiayi,Taiwan,China
- 2. Institute of Molecular Biology,National Chung Cheng University,Chiayi,Taiwan,China Department of Medical Research,Ditmanson Medical Foundation Chiayi Christian Hospital,Chiayi,Taiwan,China
- 3. Department of Pediatrics,Ditmanson Medical Foundation Chiayi Christian Hospital,Chiayi,Taiwan,China
- 4. Department of Neurosurgery,Chang Gung Memorial Hospital,Chiayi,Taiwan,China College of Medicine,Chang Gung University,Taoyuan,Taiwan,China
- 5. Department of Neurosurgery,Chang Gung Memorial Hospital,Chiayi,Taiwan,China Department of Biochemical Science and Technology,National Chiayi University,Chiayi,Taiwan,China
- 6. Department of Biochemical Science and Technology,National Chiayi University,Chiayi,Taiwan,China
- 折叠
摘要
关键词
Glioblastoma(GBM)/temozolomide(TMZ)/drug resistance/MiR-152-3p/transforming growth factoralpha(TGF-α)分类
医药卫生引用本文复制引用
Chun-Nun Chao,Chiung-Yao Fang,Chia-Hsin Hou,Jen-Tsung Yang,Yu-Ping Wu,Jui-Chieh Chen..miR-152-3p Overcomes Temozolomide Resistance in Glioblastoma by Targeting TGF-αand Enhancing Apoptosis[J].Oncology Research,2026,34(9):P.496-513,18.基金项目
supported by Ditmanson Medical Foundation Chia-Yi Christian Hospital,grant number R113-059。 （）
